Evidence map›Paper›PMID 41412799›Full record

ReviewGenes & development2026

Nuclear receptor coregulator interactions: beyond the switch.

F Nafrisha Cassim Bawa, Mitchell A Lazar

Abstract readReview
In one paragraph

Review in Genes & development, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

F Nafrisha Cassim BawaInstitute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Mitchell A LazarInstitute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA; lazar@pennmedicine.upenn.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nuclear receptors (NRs) are ligand-regulated transcription factors (TFs) that respond to hormonal, nutritional, and environmental signals. NRs as druggable targets are known for their therapeutic potential in treating a wide range of diseases, including metabolic disorders, inflammatory conditions, and various cancers. Due to their structure and ability to interact with DNA, ligands, and other proteins, NR transcriptional regulatory capacity is fine-tuned through dynamic interactions with a disparate array of coregulators, including coactivators and corepressors that form an intricate network that integrates multiple signaling and metabolic pathways. This review synthesizes insights into the functional interactions between NRs and the modulators of transcription, focusing on interactions between NRs and coregulators and how their model of interaction has evolved from a binary switch to a coregulator shift mechanism in regulating ligand-dependent transcription. These nuanced multifaceted interactions collectively direct dynamic gene expression by NRs across multiple tissues in physiology and diseases.

Indexed as

Gene Expression RegulationReceptors, Cytoplasmic and NuclearAnimalsHumansLigandsProtein BindingSignal TransductionTranscription FactorsTranscription, GeneticLigandsReceptors, Cytoplasmic and NuclearTranscription Factorscoactivatorscoregulatorscorepressorshormone actionnuclear receptors

Identifiers

PMID41412799
PMCPMC12863189

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.